FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

被引:10
作者
Georgina Turcott, Jenny [1 ]
Onate-Ocana, Luis F. [2 ]
Soca-Chafre, Giovanny [3 ]
Ramirez-Tirado, Laura-Alejandra [3 ]
Flores-Estrada, Diana [1 ]
Lucia Zatarain-Barron, Zyanya [1 ]
Arrieta, Oscar [1 ]
机构
[1] Natl Canc Inst Mexico INCan, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Natl Canc Inst Mexico INCan, Div Surg, Clin Res Div, Mexico City, DF, Mexico
[3] Natl Canc Inst Mexico INCan, Expt Oncol Lab, Mexico City, DF, Mexico
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2019年 / 71卷 / 03期
关键词
QUALITY-OF-LIFE; NUTRITIONAL-STATUS; ASSOCIATION; VALIDATION; ANAMORELIN; PROGNOSIS; THERAPY; DISEASE; IMPACT;
D O I
10.1080/01635581.2018.1506488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer (LC) has a high rate of anorexia, which negatively affects quality-of-life and prognosis; however prevalence values may vary as per diagnostic test. There is no standard for anorexia diagnosis, currently the anorexia cachexia scale (A/CS) has been proposed as a tool for diagnosing anorexia with a consensus cutoff value of <= 24, nonetheless a validated cutoff value is required. The A/CS was evaluated in advanced Non-Small Cell Lung Cancer (NSCLC) patients to establish a cutoff value. The appetite item from the QLQ-C30 questionnaire and survival served as a standard reference. The cutoff value was associated with clinical and nutritional characteristics along with quality-of-life. Three hundred and twelve (312) NSCLC patients were evaluated. The mean A/CS value was 31 +/- 9 and the identified cutoff value was 32.5 (sensitivity: 80.3% and specificity: 85%). The proportion of anorexia accurately diagnosed with the cutoff value of 24 was 26%, while with 32 it was 50%. The A/CS cutoff value of 32 was associated with clinical parameters, nutritional consumption, and quality-of-life, and independently associated with overall survival. A score of <= 32 in the A/CS is proposed for anorexia diagnosis in order to identify patients at risk of complications involving malnutrition related to LC.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [41] The Clinical Value of Lymphatic Micrometastases in Patients with Non-small Cell Lung Cancer
    Verhagen, Ad F.
    Bulten, Johan
    Shirango, Hebste
    Thunnissen, Frederik B. J. M.
    van der Drift, Miep A.
    van der Bruggen, Wouter
    Tjan-Heijnen, Vivianne C. G.
    van Swieten, Henry A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1201 - 1205
  • [42] Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients
    Zhu Chihong
    Ling Yutian
    Wan Danying
    Jiang Ruibin
    Sheng Huaying
    Gu Linhui
    Feng Jianguo
    ONCOTARGET, 2017, 8 (28) : 45577 - 45584
  • [43] Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab
    Oyanagi, Jun
    Koh, Yasuhiro
    Sato, Koichi
    Mori, Keita
    Teraoka, Shunsuke
    Akamatsu, Hiroaki
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    LUNG CANCER, 2019, 132 : 107 - 113
  • [44] Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patients
    Chen, Tao
    Zhou, Fangyu
    Jiang, Weili
    Mao, Rui
    Zheng, Hui
    Qin, Linlin
    Chen, Chang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (06) : 2251 - 2266
  • [45] Diagnosis, testing, treatment, and outcomes among patients with advanced non-small cell lung cancer in the United States
    Yang, Mo
    Macewan, Joanna P.
    Boppudi, Sai Sriteja
    Mcclain, Monica R.
    O'Hara Jr, Richard M.
    Paik, Paul K.
    CANCER MEDICINE, 2023, 12 (24): : 21605 - 21614
  • [46] Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy
    Jiang Shu-long
    Liu Hong-jie
    Liu Zhao-chun
    Liu Ning
    Liu Rui
    Kang, Young-Reep
    Ji, Joong-Gu
    Zhang Chao
    Hua Bao-jin
    Kang, Shin-Jyung
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2017, 23 (05) : 331 - 337
  • [47] Surgical management of advanced non-small cell lung cancer
    Varela, Gonzalo
    Thomas, Pascal Alexandre
    JOURNAL OF THORACIC DISEASE, 2014, 6 : S217 - S223
  • [48] Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy
    Xu, Xiaohong
    Chen, Gang
    Fan, Shaonan
    Zhang, Qi
    Huang, Wenhan
    Chen, Jingyao
    Ji, Weixing
    Ma, Jintao
    He, Jian
    JOURNAL OF THORACIC DISEASE, 2024, 16 (01) : 479 - 490
  • [49] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
    Keating, Gillian M.
    TARGETED ONCOLOGY, 2016, 11 (06) : 825 - 835
  • [50] Therapeutic vaccines for advanced non-small cell lung cancer
    Cortes-Jofre, Marcela
    Rueda-Etxebarria, Mikel
    Orillard, Emeline
    Jimenez Tejero, Elena
    Rueda, Jose-Ramon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (03):